Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127139511 | 12713951 | 1 | I | 20150519 | 20150610 | 20160905 | 20160905 | EXP | US-ROCHE-1592391 | ROCHE | 71.00 | YR | F | Y | 69.00000 | KG | 20160905 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127139511 | 12713951 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | DATE OF LAST DOSE PRIOR TO SAE OF BEVACIZUMAB - 28/OCT/2014 | 125085 | 15 | MG/KG | SOLUTION FOR INFUSION | |||||||
| 127139511 | 12713951 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 125085 | 204 | MG | SOLUTION FOR INFUSION | ||||||||
| 127139511 | 12713951 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 125085 | SOLUTION FOR INFUSION | ||||||||||
| 127139511 | 12713951 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 125085 | SOLUTION FOR INFUSION | ||||||||||
| 127139511 | 12713951 | 5 | SS | IPILIMUMAB | IPILIMUMAB | 1 | Intravenous (not otherwise specified) | DATE OF LAST DOSE PRIOR TO SAE OF BEVACIZUMAB -31/MAR/2015 | 0 | 3 | MG/KG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127139511 | 12713951 | 1 | Malignant melanoma |
| 127139511 | 12713951 | 5 | Malignant melanoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127139511 | 12713951 | HO |
| 127139511 | 12713951 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127139511 | 12713951 | Abdominal pain upper | |
| 127139511 | 12713951 | Alanine aminotransferase increased | |
| 127139511 | 12713951 | Anaemia | |
| 127139511 | 12713951 | Blood alkaline phosphatase increased | |
| 127139511 | 12713951 | Cholecystitis | |
| 127139511 | 12713951 | Chronic kidney disease | |
| 127139511 | 12713951 | Headache | |
| 127139511 | 12713951 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127139511 | 12713951 | 1 | 20140325 | 0 | ||
| 127139511 | 12713951 | 2 | 20141230 | 0 | ||
| 127139511 | 12713951 | 3 | 20150306 | 0 | ||
| 127139511 | 12713951 | 4 | 20140617 | 0 | ||
| 127139511 | 12713951 | 5 | 20140325 | 0 |